HCC Liver Cancer
Our Product is a unique di-substituted aminothiazole which has been demonstrated to have high selective toxicity to HCC will little toxicity to non HCC liver cell lines. The product has been evaluated in human liver cells with convincing initial results.
|
Non Statin LDL
Our product is a Triazolepyrmidizole that has been demonstrated to lower circulating ApoB/LDL levels by 30-40% in animal studies using humanized liver. The product targets direct reduction at the intracellular level
|
Blumberg Institute
The Baruch S. Blumberg Institute has the largest concentration of nonprofit scientists working on the problem of hepatitis B and liver cancer in the United States. The research being conducted by the Blumberg Institute’s research faculty is internationally recognized as some of the most exciting and promising work. |
|
|